ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,310
Screening encounters
3,825
Diagnostic referrals
727
Outstanding pathways
279

Screening pathway

  1. Screening3,825Encounters
  2. Positive finding1,322Documented findings
  3. Referral727Diagnostic referrals
  4. Follow-up848Diagnostic visits
  5. Outcome448Resolved pathways

Stage totals use different units. Pending pathways: 279. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0109 · EXP-0109Synthetic · Site D

Full participant history through 2026-08-14, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-02-03
  4. · Diagnostic referral · EXP-0109-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Barrier documented · Transport difficulty
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Missed
  11. · Diagnostic booking · Rebooking
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · High-grade lesion
  15. · Follow-up disposition · Resolved · EXP-0109-T-R
  16. · Treatment · Synthetic precancer treatment
  17. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2026-11-13
  18. · Screening · HPV DNA · Repeat · Prior VIA positive
  19. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

3310 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0140 · Expanded synthetic participant 0140Site A — Urban Referral Hub
EXP-0142 · Expanded synthetic participant 0142Site C — Rural Outreach Programme
EXP-0144 · Expanded synthetic participant 0144Site E — Resource-Constrained Navigation Programme
EXP-0145 · Expanded synthetic participant 0145Site E — Resource-Constrained Navigation Programme
EXP-0149 · Expanded synthetic participant 0149Site A — Urban Referral Hub
EXP-0150 · Expanded synthetic participant 0150Site E — Resource-Constrained Navigation Programme
EXP-0151 · Expanded synthetic participant 0151Site D — Community Engagement Programme
EXP-0154 · Expanded synthetic participant 0154Site B — Peri-Urban Access Programme
EXP-0155 · Expanded synthetic participant 0155Site E — Resource-Constrained Navigation Programme
EXP-0156 · Expanded synthetic participant 0156Site A — Urban Referral Hub
EXP-0158 · Expanded synthetic participant 0158Site B — Peri-Urban Access Programme
EXP-0160 · Expanded synthetic participant 0160Site B — Peri-Urban Access Programme
EXP-0161 · Expanded synthetic participant 0161Site E — Resource-Constrained Navigation Programme
EXP-0163 · Expanded synthetic participant 0163Site C — Rural Outreach Programme
EXP-0164 · Expanded synthetic participant 0164Site C — Rural Outreach Programme
EXP-0165 · Expanded synthetic participant 0165Site D — Community Engagement Programme
EXP-0166 · Expanded synthetic participant 0166Site D — Community Engagement Programme
EXP-0167 · Expanded synthetic participant 0167Site C — Rural Outreach Programme
EXP-0170 · Expanded synthetic participant 0170Site A — Urban Referral Hub
EXP-0171 · Expanded synthetic participant 0171Site C — Rural Outreach Programme
EXP-0172 · Expanded synthetic participant 0172Site C — Rural Outreach Programme
EXP-0175 · Expanded synthetic participant 0175Site B — Peri-Urban Access Programme
EXP-0176 · Expanded synthetic participant 0176Site A — Urban Referral Hub
EXP-0179 · Expanded synthetic participant 0179Site D — Community Engagement Programme
EXP-0182 · Expanded synthetic participant 0182Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1512
HPV DNA
1766
Cytology
547

Navigation activity

Barrier documented
632
Contact attempt
1072
Navigation intervention
270
Diagnostic booking
897
Diagnostic visit
848

Documented barriers

Contact difficulty
210
Transport difficulty
198
Appointment coordination
224

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.